樂觀
$146.16
情境價格
$247.740
+8.299 (+3.35%)收盤時
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and others. It also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as owns a urology management services organization (MSO). Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
Cardinal Health Inc is a good buy right now due to its strong recent performance and positive growth outlook. The current price is $237.57, and analysts have set price targets as high as $280, indicating potential upside of over 17%. Additionally, the company has shown a year-to-date change of +15.48% and a one-year change of +53.96%, reflecting robust growth. However, the main risk is its current ratio of 0.88, indicating potential liquidity concerns.
RBC Capital
$276
2026-08-19
RBC Capital
2026-08-19
目標價
$276
TD Cowen
$280
2026-08-13
TD Cowen
2026-08-13
目標價
$280
JPMorgan
$260
2026-08-13
JPMorgan
2026-08-13
目標價
$260
Barclays
$275
2026-08-13
Barclays
2026-08-13
目標價
$275
Morgan Stanley
$265
2026-08-12
Morgan Stanley
2026-08-12
目標價
$265
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Wall Street Investor Sentiment Deepens Divide

US Stocks Decline Due to Inflation Data

Wall Street Rally on Friday, Tech Stocks Rebound

Market Dynamics and Investment Strategies Analysis

Market Update: S&P 500 Stabilizes Amid Bond Yield Fluctuations
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and others. It also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as owns a urology management services organization (MSO). Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination. It operates in the Healthcare sector (WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRI industry).
Cardinal Health Inc is a good buy right now due to its strong recent performance and positive growth outlook. The current price is $237.57, and analysts have set price targets as high as $280, indicating potential upside of over 17%. Additionally, the company has shown a year-to-date change of +15.48% and a one-year change of +53.96%, reflecting robust growth. However, the main risk is its current ratio of 0.88, indicating potential liquidity concerns.
16 analysts cover CAH: 1 rate it Buy, 15 Hold and 0 Sell. The average price target is 225.18.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。